Omada Health (NASDAQ: OMDA) CFO logs small option exercise and 300-share sale

Rhea-AI Filing Summary

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported a small, routine insider transaction involving company common stock. On June 30, 2026, he exercised stock options to acquire 300 shares at $8.28 per share and sold 300 shares in an open-market transaction at $22.00 per share. After these transactions, he directly held 115,409 shares of Omada Health common stock. A footnote states the sale was made under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2026, indicating the timing was planned in advance rather than a discretionary market-timing decision.

Insider Trade Summary 10b5-1

Net Seller: 300 shares ($6,600)

Net Sell 3 txns

Insider Cook Steven L.

Role Chief Financial Officer

Sold 300 shs ($7K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	300	$0.00	--
Exercise	Common Stock	300	$8.28	$2K
Sale	Common Stock	300	$22.00	$7K

Holdings After Transaction: Stock Option (Right to Buy) — 333,032 shares (Direct, null); Common Stock — 115,709 shares (Direct, null)

Footnotes (1)

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. 100% of the shares subject to the option are fully vested and exercisable.

Key Figures

Shares sold: 300 shares Sale price: $22.00/share Option exercise size: 300 shares +3 more

6 metrics

Shares sold 300 shares Open-market sale of common stock on June 30, 2026

Sale price $22.00/share Price per share for 300 common shares sold

Option exercise size 300 shares Shares acquired via stock option exercise

Option exercise price $8.28/share Exercise price for stock option converted into common shares

Shares held after transaction 115,409 shares Direct common stock ownership after June 30, 2026 trades

Options remaining 333,032 shares Stock Option (Right to Buy) shares outstanding after 300 exercised

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy), derivative security, open-market sale

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" for a derivative transaction."

derivative security financial

"transaction_code_description: "Exercise or conversion of derivative security" for the option exercise."

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

open-market sale financial

"transaction_action: "open-market sale" for the 300 common shares sold."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 08:04 PM Accepted by SEC EDGAR 07/02/2026 - 08:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Steven L.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		M		300	A	$8.28	115,709	D
Common Stock	06/30/2026		S(1)		300	D	$22	115,409	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$8.28	06/30/2026		M			300	(2)	07/19/2031	Common Stock	300	$0	333,032	D

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

2. 100% of the shares subject to the option are fully vested and exercisable.

	/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Omada Health (OMDA) report for CFO Steven L. Cook?

Omada Health CFO Steven L. Cook reported exercising stock options for 300 shares and selling 300 common shares. Both transactions occurred on June 30, 2026, and involved routine insider activity rather than a large change in his overall ownership position.

At what prices did the Omada Health (OMDA) CFO exercise and sell shares?

The CFO exercised stock options at $8.28 per share and sold 300 Omada Health common shares at $22.00 per share. This reflects an option exercise followed by an open-market sale at a significantly higher market price on the same transaction date.

How many Omada Health (OMDA) shares does the CFO hold after this Form 4 filing?

Following the reported transactions, CFO Steven L. Cook directly holds 115,409 shares of Omada Health common stock. The filing shows this updated ownership figure after the 300-share sale and related option exercise recorded on June 30, 2026.

Was the Omada Health (OMDA) CFO’s share sale part of a 10b5-1 trading plan?

Yes. A footnote states the transaction was made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026. Such plans pre-schedule trades, indicating the sale’s timing was arranged in advance rather than based on short-term market movements.

What stock option activity did Omada Health (OMDA) disclose for its CFO?

The filing shows a stock option labeled as a “Stock Option (Right to Buy)” with a $8.28 exercise price. On June 30, 2026, 300 option shares were exercised into common stock, leaving 333,032 option shares outstanding and fully vested and exercisable, according to a footnote.